531633 Stock Overview
Lincoln Pharmaceuticals Limited engages in manufacturing and trading of pharmaceutical products in India and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 4/6 |
| Financial Health | 6/6 |
| Dividends | 4/6 |
Rewards
Risk Analysis
No risks detected for 531633 from our risk checks.
Lincoln Pharmaceuticals Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹592.95 |
| 52 Week High | ₹754.25 |
| 52 Week Low | ₹365.40 |
| Beta | 0.68 |
| 1 Month Change | -1.38% |
| 3 Month Change | -10.30% |
| 1 Year Change | 51.75% |
| 3 Year Change | 134.09% |
| 5 Year Change | 227.60% |
| Change since IPO | 2,370.63% |
Recent News & Updates
Recent updates
Shareholder Returns
| 531633 | IN Pharmaceuticals | IN Market | |
|---|---|---|---|
| 7D | 2.2% | -0.1% | 1.8% |
| 1Y | 51.7% | 55.9% | 46.4% |
Return vs Industry: 531633 underperformed the Indian Pharmaceuticals industry which returned 55.3% over the past year.
Return vs Market: 531633 exceeded the Indian Market which returned 46.1% over the past year.
Price Volatility
| 531633 volatility | |
|---|---|
| 531633 Average Weekly Movement | 5.6% |
| Pharmaceuticals Industry Average Movement | 6.0% |
| Market Average Movement | 6.9% |
| 10% most volatile stocks in IN Market | 10.1% |
| 10% least volatile stocks in IN Market | 4.2% |
Stable Share Price: 531633 has not had significant price volatility in the past 3 months.
Volatility Over Time: 531633's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1979 | 1,645 | Mahendrabhai Patel | www.lincolnpharma.com |
Lincoln Pharmaceuticals Limited engages in manufacturing and trading of pharmaceutical products in India and internationally. The company provides products in the areas of cough and cold, anti-allergic, and anti-asthmatics; sterile ophthalmic eye drops and ointment; anti-malarial; vitamins, minerals, and antioxidants; anti-bacterial, anti-viral, and anti-fungal vitamins; analgesic and anti-pyretic; anti-psychotic, anti-convulsant, anti-depressant, and anti-diabetic; cardiac anti-hypertensives, and diuretic; and anti-diarrheal, anti-spasmodic, and laxative, as well as dermatologist preparations, gynecological products, gastrointestinal rang, otology products, and phosphodiesterase type 5 inhibitor and general anesthetics. It also offers branded generics.
Lincoln Pharmaceuticals Limited Fundamentals Summary
| 531633 fundamental statistics | |
|---|---|
| Market cap | ₹11.88b |
| Earnings (TTM) | ₹872.70m |
| Revenue (TTM) | ₹5.51b |
13.6x
P/E Ratio2.2x
P/S RatioIs 531633 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 531633 income statement (TTM) | |
|---|---|
| Revenue | ₹5.51b |
| Cost of Revenue | ₹2.58b |
| Gross Profit | ₹2.93b |
| Other Expenses | ₹2.06b |
| Earnings | ₹872.70m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
May 30, 2024
| Earnings per share (EPS) | 43.57 |
| Gross Margin | 53.21% |
| Net Profit Margin | 15.85% |
| Debt/Equity Ratio | 0.2% |
How did 531633 perform over the long term?
See historical performance and comparison